Clinical Trial Update: Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the effects of Sativex and oral THC on attention, memory, and brain activity in cannabis dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Dependence

Drugs mentioned

• Oral THC (dronabinol)
• Sativex (nabiximol)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cannabis, Dependence | Phase 1 | Status: COMPLETED